^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

simtuzumab (GS 6624)

i
Other names: GS 6624, AB 0024, AB-0024, AB0024, GS-6624
Associations
Trials
Company:
Gilead
Drug class:
VEGFR inhibitor, CXCL12 inhibitor, TGF-β1 inhibitor, Connective tissue growth factor inhibitor, LOXL2 inhibitor
Associations
Trials